Evidence map›Paper›PMID 39809953›Full record

Trial reportLasers in medical science2025

Fractional CO

Ghasem Rahmatpour Rokni, Mohammad Malekan, Sepide Azade, Amir Mohammad Beyzaee, Keyvan Heydari, Sahar Fallah, Armaghan Kazeminejad, Shirin Zaresharifi, Nasim Gholizadeh

Abstract readRandomized Controlled TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ghasem Rahmatpour RokniDepartment of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad MalekanStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Sepide AzadeMazandaran University of Medical Sciences, Sari, Iran.
Amir Mohammad BeyzaeeDepartment of Dermatology, Mazandaran University of Medical Sciences, Sari, Iran.
Keyvan HeydariMazandaran University of Medical Sciences, Sari, Iran.
Sahar FallahDepartment of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Armaghan KazeminejadDepartment of Dermatology, Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shirin ZaresharifiSkin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nasim GholizadehDepartment of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. nasim.gh89@gmail.com.ORCID http://orcid.org/0000-0002-7234-270X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitiligo is a chronic depigmenting condition that causes amelanotic macules and patches on the skin. Despite various treatment options, treating vitiligo is a challenge. This study aimed to evaluate the combination of laser CO

Indexed as

Lasers, GasLow-Level Light TherapyUltraviolet TherapyVitiligoAdultCombined Modality TherapyFemaleHumansMaleMiddle AgedProspective StudiesTreatment OutcomeYoung AdultFractional CO2 laserNB-UVBVitiligo

Identifiers

PMID39809953

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.